Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Index by author

June 2009; Volume 29,Issue 6
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Adachii, MITSURU

    1. You have access
      Combination Effect between Bortezomib and Tumor Necrosis Factor α on Gefitinib-resistant Non-small Cell Lung Cancer Cell Lines
      SOJIRO KUSUMOTO, TOMOHIDE SUGIYAMA, KOICHI ANDO, TAKAMICHI HOSAKA, HIROO ISHIDA, TAKAO SHIRAI, TOSHIMITSU YAMAOKA, KENTARO OKUDA, TAKASHI HIROSE, TSUKASA OHNISHI, FUMIKO INOUE, TOMOKO KANOME, TSUYOKI KADOFUKU, NAGAHIRO SAIJO, MITSURU ADACHII and TOHRU OHMORI
      Anticancer Research June 2009, 29 (6) 2315-2322;
  2. Agachan, BEDİA

    1. You have access
      Apurinic/Apyrimidinic Endonuclease (APE1) Gene Polymorphisms and Lung Cancer Risk in Relation To Tobacco Smoking
      BEDİA AĞAÇHAN, ÖZLEM KÜÇÜKHÜSEYİN, PINAR AKSOY, AKİF TURNA, İLHAN YAYLIM, UZAY GÖRMÜŞ, ARZU ERGEN, ÜMİT ZEYBEK, BURAK DALAN and TURGAY ISBİR
      Anticancer Research June 2009, 29 (6) 2417-2420;
  3. Akamatsu, KANAKO

    1. You have access
      Riluzole Induces Apoptotic Cell Death in Human Prostate Cancer Cells via Endoplasmic Reticulum Stress
      KANAKO AKAMATSU, MASA-AKI SHIBATA, YUKO ITO, YOSHIRO SOHMA, HARUHITO AZUMA and YOSHINORI OTSUKI
      Anticancer Research June 2009, 29 (6) 2195-2204;
  4. Akporiaye, EMMANUEL T.

    1. You have access
      An Orally Active Small Molecule TGF-β Receptor I Antagonist Inhibits the Growth of Metastatic Murine Breast Cancer
      MATTHEW P. RAUSCH, TOBIAS HAHN, LALITHA RAMANATHAPURAM, DEBORAH BRADLEY-DUNLOP, DARUKA MAHADEVAN, MELANIA E. MERCADO-PIMENTEL, RAYMOND B. RUNYAN, DAVID G. BESSELSEN, XIAMEI ZHANG, H.-KAM CHEUNG, WEN-CHERNG LEE, LEONA E. LING and EMMANUEL T. AKPORIAYE
      Anticancer Research June 2009, 29 (6) 2099-2109;
  5. Aksoy, PINAR

    1. You have access
      Apurinic/Apyrimidinic Endonuclease (APE1) Gene Polymorphisms and Lung Cancer Risk in Relation To Tobacco Smoking
      BEDİA AĞAÇHAN, ÖZLEM KÜÇÜKHÜSEYİN, PINAR AKSOY, AKİF TURNA, İLHAN YAYLIM, UZAY GÖRMÜŞ, ARZU ERGEN, ÜMİT ZEYBEK, BURAK DALAN and TURGAY ISBİR
      Anticancer Research June 2009, 29 (6) 2417-2420;
  6. Alexander, JAN

    1. You have access
      5-Hydroxymethylfurfural and 5-Sulfooxymethylfurfural Increase Adenoma and Flat ACF Number in the Intestine of Min/+ Mice
      CAMILLA SVENDSEN, TRINE HUSØY, HANSRUEDI GLATT, JAN ERIK PAULSEN and JAN ALEXANDER
      Anticancer Research June 2009, 29 (6) 1921-1926;
  7. Amaral, LEONARD

    1. You have access
      Demonstration of the Activity of P-glycoprotein by a Semi-automated Fluorometric Method
      GABRIELLA SPENGLER, MIGUEL VIVEIROS, MARTA MARTINS, LILIANA RODRIGUES, ANA MARTINS, JOZSEF MOLNAR, ISABEL COUTO and LEONARD AMARAL
      Anticancer Research June 2009, 29 (6) 2173-2177;
  8. Anant, SHRIKANT

    1. You have access
      14-3-3σ-Dependent Resistance to Cisplatin
      ZHIYONG HAN, KONSTANTINOS DIMAS, XUEFEI TIAN, YONGBAO WANG, HIROMICHI HEMMI, KANAE YAMADA, NAOYUKI KATO, PANAYOTIS PANTAZIS, RAMA J. RAMANUJAM, SHRIKANT ANANT, JAMES H. WYCHE and COURTNEY W. HOUCHEN
      Anticancer Research June 2009, 29 (6) 2009-2014;
  9. Ando, KOICHI

    1. You have access
      Combination Effect between Bortezomib and Tumor Necrosis Factor α on Gefitinib-resistant Non-small Cell Lung Cancer Cell Lines
      SOJIRO KUSUMOTO, TOMOHIDE SUGIYAMA, KOICHI ANDO, TAKAMICHI HOSAKA, HIROO ISHIDA, TAKAO SHIRAI, TOSHIMITSU YAMAOKA, KENTARO OKUDA, TAKASHI HIROSE, TSUKASA OHNISHI, FUMIKO INOUE, TOMOKO KANOME, TSUYOKI KADOFUKU, NAGAHIRO SAIJO, MITSURU ADACHII and TOHRU OHMORI
      Anticancer Research June 2009, 29 (6) 2315-2322;
  10. Antonescu, CRISTINA

    1. You have access
      Combination of PI3K/mTOR Inhibition Demonstrates Efficacy in Human Chordoma
      JOSEPH SCHWAB, CRISTINA ANTONESCU, PATRICK BOLAND, JOHN HEALEY, ANDREW ROSENBERG, PETUR NIELSEN, JOHN IAFRATE, THOMAS DELANEY, SAM YOON, EDWIN CHOY, DAVID HARMON, KEVIN RASKIN, CAO YANG, HENRY MANKIN, DEMPSEY SPRINGFIELD, FRANCIS HORNICEK and ZHENFENG DUAN
      Anticancer Research June 2009, 29 (6) 1867-1871;
« Previous (Pages : 1 2 3 4 5 6 ... 52) Next »
Back to top
PreviousNext

In this issue

Anticancer Research: 29 (6)
Anticancer Research
Vol. 29, Issue 6
June 2009
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire